These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8897879)

  • 21. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat.
    MacKendrick W; Caplan M; Hsueh W
    Pediatr Res; 1993 Aug; 34(2):222-8. PubMed ID: 8233729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats.
    Nandi J; Saud B; Zinkievich JM; Palma DT; Levine RA
    Dig Dis Sci; 2008 Jan; 53(1):123-32. PubMed ID: 17503181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.
    Banerjee AK; Peters TJ
    Gut; 1990 Dec; 31(12):1358-64. PubMed ID: 1979954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of difluoromethylornithine (DFMO) on NSAID-induced intestinal injury in rats.
    Erickson RA; Rivera N
    Dig Dis Sci; 1992 Dec; 37(12):1833-9. PubMed ID: 1473432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microcirculatory changes in experimental mesenteric longitudinal ulcers of the small intestine in rats.
    Shimizu K; Koga H; Iida M; Haruma K
    Dig Dis Sci; 2007 Nov; 52(11):3019-28. PubMed ID: 17393313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?
    Fornai M; Antonioli L; Colucci R; Pellegrini C; Giustarini G; Testai L; Martelli A; Matarangasi A; Natale G; Calderone V; Tuccori M; Scarpignato C; Blandizzi C
    J Pharmacol Exp Ther; 2014 Jan; 348(1):86-95. PubMed ID: 24135073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early histological features of small intestinal injury induced by indomethacin.
    Anthony A; Dhillon AP; Nygard G; Hudson M; Piasecki C; Strong P; Trevethick MA; Clayton NM; Jordan CC; Pounder RE
    Aliment Pharmacol Ther; 1993 Feb; 7(1):29-39. PubMed ID: 8439635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
    Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
    J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ileal inducible nitric oxide synthase mRNA expression in response to stress is modified in Sprague-Dawley rats exposed to a previous intestinal inflammation.
    Jorge E; Vergara P; Martin MT
    Stress; 2012 Jan; 15(1):62-73. PubMed ID: 21790346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes.
    Nygård G; Anthony A; Piasecki C; Trevethick MA; Hudson M; Dhillon AP; Pounder RE; Wakefield AJ
    Gastroenterology; 1994 Mar; 106(3):567-75. PubMed ID: 8119525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
    Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
    J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction.
    Li YM; Wang HB; Zheng JG; Bai XD; Zhao ZK; Li JY; Hu S
    World J Gastroenterol; 2015 Oct; 21(38):10853-65. PubMed ID: 26478676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oral curcumin on indomethacin-induced small intestinal damage in the rat.
    Menozzi A; Pozzoli C; Poli E; Martelli M; Martelli L; Zullian C; Bertini S
    Drug Discov Ther; 2009 Apr; 3(2):71-6. PubMed ID: 22495480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of vasoactive intestinal polypeptide and gastrin-releasing peptide on small bowel microcirculation and mucosal injury after hepatic ischemia/reperfusion in rats.
    Leister I; Sydow J; Stojanovic T; Füzesi L; Sattler B; Heuser M; Becker H; Markus PM
    Int J Colorectal Dis; 2005 Jan; 20(1):42-8. PubMed ID: 15602648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of Notoginsenoside R1 on intestinal ischemia-reperfusion injury in rats.
    Li C; Li Q; Liu YY; Wang MX; Pan CS; Yan L; Chen YY; Fan JY; Han JY
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(2):G111-22. PubMed ID: 24232000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
    Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Involvement of endogenous tachykinins in the development of jejunal mucosa injury induced by on-steroidal anti-inflammatory drugs].
    Sendur P; Ceranowicz P; Sendur R; Cieszkowski J; Warzecha Z; Dembiński A
    Przegl Lek; 2013; 70(2):48-52. PubMed ID: 23879003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis.
    Okuda T; Yoshida N; Takagi T; Handa O; Kokura S; Ichikawa H; Naito Y; Yoshikawa T
    Dig Dis Sci; 2008 Mar; 53(3):657-63. PubMed ID: 17763956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
    Nishio H; Hayashi Y; Terashima S; Takeuchi K
    Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.